RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Rare and unusual histological variants of prostatic carcinoma: clinical significance.
2008-01-01 Mazzucchelli, Roberta; Lopez Beltran, A.; Cheng, L.; Scarpelli, Marina; Kirkali, Z.; Montironi, Rodolfo
Rare synchronous association of vestibular schwannoma and indolent insular oligodendroglioma in a patient without neurofibromatosis: controversial issue of timing for surgical treatment of asymptomatic low-grade gliomas.
2012-01-01 Iacoangeli, Maurizio; Di Rienzo, A.; Colasanti, Roberto; Alvaro, Lorenzo; Nocchi, N.; Polonara, Gabriele; Di Somma, L. G. M.; Zizzi, Antonio; Scarpelli, Marina; Scerrati, Massimo
RAS genes in colorectal carcinoma: Pathogenesis, testing guidelines and treatment implications
2019-01-01 Saeed, O.; Lopez-Beltran, A.; Fisher, K. W.; Scarpelli, M.; Montironi, R.; Cimadamore, A.; Massari, F.; Santoni, M.; Cheng, L.
Re: Alfonso Gómez de Liaño Lista, Nick van Dijk, Guillermo de Velasco Oria de Rueda, et al. Clinical Outcome After Progressing to Frontline and Second-line Anti–PD-1/PD-L1 in Advanced Urothelial Cancer. Eur Urol 2020;77:269–76: Progression and Hyperprogression Versus Pseudoprogression: Morphologic Documentation
2020-01-01 Cimadamore, A.; Cheng, L.; Scarpelli, M.; Lopez-Beltran, A.; Mollica, V.; Montironi, R.; Massari, F.
Re: Aurelien Descazeaud, Marc Zerbib, Thierry Flam et al. Can pTO stage of prostate cancer be predicted before radical prostatectomy? Eur Urol 2006;50:1248-53.
2007-01-01 Montironi, Rodolfo; Scarpelli, Marina; Lopez Beltran, A.; Cheng, L.
Re: Bas W.G. van Rhijn, Anouk E. Hentschel, Johannes Bründl, et al. Prognostic Value of the WHO1973 and WHO2004/2016 Classification Systems for Grade in Primary Ta/T1 Non-muscle-invasive Bladder Cancer: A Multicenter European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel Study. Eur Urol Oncol 2021;4:182-91: Image Analysis, Nuclear Abnormality Index, and Pattern Recognition Analysis
2021-01-01 Cimadamore, A.; Lopez-Beltran, A.; Scarpelli, M.; Cheng, L.; Montironi, R.
Re: Daniel M. Geynisman. Anti-programmed Cell Death Protein 1 (PD-1) Antibody Nivolumab Leads to a Dramatic and Rapid Response in Papillary Renal Cell Carcinoma with Sarcomatoid and Rhabdoid Features. Eur Urol 2015;68:912-4
2016-01-01 Piva, Francesco; Santoni, Matteo; Scarpelli, Marina; Briganti, Alberto; Lopez Beltran, Antonio; Cheng, Liang; Berardi, Rossana; Montorsi, Francesco; Montironi, Rodolfo
Re: Daniel M. Geynisman. Anti-programmed cell death protein 1 (PD-1) antibody nivolumab leads to a dramatic and rapid response in papillary renal cell carcinoma with sarcomatoid and rhabdoid features. Eur Urol 2015;68:912â4
2017-01-01 Monn, M. Francesca; Cheng, Liang; Scarpelli, Marina; Lopez-Beltran, Antonio; Montironi, Rodolfo
Re: Epithelial-to-mesenchymal transition in renal neoplasms
2015-01-01 Montironi, Rodolfo; Santoni, Matteo; Scarpelli, Marina; Piva, Francesco; Lopez Beltran, Antonio; Cheng, Liang; Briganti, Alberto; Montorsi, Francesco
Re: Friederike Haidl, David Pfister, Axel Heidenreich. Re: Prostatic Artery Embolization in the Treatment of Localized Prostate Cancer: A Bicentric Prospective Proof-of-Concept Study of 12 Patients. Mordasini L, Hechelhammer L, Diener PA, et al. J Vasc Interv Radiol 2018;29:589–97. Eur Urol 2018;74:525–6: Could Morphologic Changes in Periprostatic Arteries Have an Influence on Prostatic Artery Embolization?
2019-01-01 Cimadamore, A.; Scarpelli, M.; Santoni, M.; Cheng, L.; Lopez-Beltran, A.; Montorsi, F.; Montironi, R.
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 1 Contributo su Rivista 392
- 1 Contributo su Rivista::1.1 Arti... 392
Data di pubblicazione
- 2020 - 2022 57
- 2010 - 2019 190
- 2000 - 2009 74
- 1990 - 1999 45
- 1980 - 1989 23
- 1979 - 1979 3
Editore
- S Karger AG:Allschwilerstrasse 10... 7
- Blackwell Science Limited:PO Box ... 5
- BMJ / British Medical Journal Pub... 5
- Science Printers and Publishers I... 4
- Springer Verlag Germany:Tiergarte... 4
- -Philadelphia Usa: W.B. Saunders... 1
- Dustri-Verlag:Bajuwarenring 4, D-... 1
- Editrice Kurtis Srl:via Luigi Zoj... 1
- International Institute of Antica... 1
- London : Nature Pub. Group, [2004]- 1
Rivista
- EUROPEAN UROLOGY 53
- ANALYTICAL AND QUANTITATIVE CYTOL... 25
- PATHOLOGY RESEARCH AND PRACTICE 14
- JOURNAL OF CLINICAL PATHOLOGY 13
- BJU INTERNATIONAL 10
- FUTURE ONCOLOGY 10
- EXPERT REVIEW OF MOLECULAR DIAGNO... 9
- CURRENT DRUG TARGETS 8
- HISTOPATHOLOGY 8
- HUMAN PATHOLOGY 8
Keyword
- Humans 26
- Prostate cancer 25
- Oncology 16
- Immunotherapy 15
- Urology 14
- Cancer Research 11
- Renal cell carcinoma 11
- immunotherapy 10
- Male 10
- prostate cancer 10
Lingua
- eng 384
- ita 3
- fre 2
- spa 1
Accesso al fulltext
- no fulltext 389
- open 3